Talking Euretina

Whipsmart Media
  • 5.0 (2)
  • Science
  • Updated fortnightly

Expert Discussions from the World of Retina: Exploring the latest developments in the field with world-renowned leaders. It will feature a monthly subspecialty journal club, panel discussions and interviews with key opinion leaders.

  1. 4 days ago

    Episode 86: The Dark Side of the Moon: Prof Frank Holz on Dry AMD and a Career in Retina

    Ahead of his EURETINA Lecture in Vienna — "The Dark Side of the Moon: New Horizons in Dry AMD" — Past President Prof. Frank Holz joins President Prof. Nicole Eter for a wide-ranging conversation on his career, from pioneering retinal imaging to restoring central vision in advanced AMD, and why dry AMD may finally be at a turning point. Catch the lecture live in Vienna on Thursday 1 October

  2. 3 Aug

    Episode 85: Masquerade Syndromes: When Uveitis Isn't Uveitis

    In tertiary practice, masquerades account for around 5% of uveitis cases — and missing one can cost sight, or life. Prof Bahram Bodaghi is joined by Prof Elisabetta Miserocchi and Prof Isabelle Audo on vitreoretinal lymphoma, the limits of diagnostic vitrectomy, IL-10:IL-6 ratios and MYD88, the paraneoplastic retinopathies CAR, MAR and BDUMP, and the inherited retinal diseases that quietly mimic inflammation. Essential listening before reaching for steroids

  3. 21 Jul

    Episode 84: Inside Euretina Innovation Spotlight: Retina, Industry & Regulators

    The Euretina Innovation Spotlight returns to Vienna on 30 September, bringing clinicians, industry, investors and regulators around one table. Prof. Anat Loewenstein, Prof. Nicole Eter and Dr. Kourous Rezaei tell Jonathan McCrea why innovation in retina is moving faster than ever, what the return of the EMA's Jane Mosley means for bridging Europe and the US, and why this exchange of ideas is something a traditional congress simply can't offer

  4. 13 Jul

    Episode 83: Retinopathy of Prematurity: Has Anti-VEGF Changed the Game?

    Anti-VEGF has transformed how we treat retinopathy of prematurity — but at what long-term cost? Dr Kanmin Xue chairs a global discussion with Dr Domenico Lepore, Prof Wei-Chi Wu and Prof Andreas Stahl on injections versus laser, the RAINBOW and FIREFLEYE trial data, managing peripheral avascular retina, and why these babies may need follow-up for life. A frank look at the questions the evidence hasn't yet answered.

  5. 26 Jun

    Episode 82: Uveal Melanoma in Pregnancy: To Treat or to Wait?

    A diagnosis of uveal melanoma during pregnancy forces an agonising question: treat now, or wait? Dr Emine Kiliç chairs a multidisciplinary discussion with Dr Iwona Rospond-Kubiak (Poznań), Prof. Antonia Joussen (Charité, Berlin) and radiation oncologist Dr Adam Chicheł on plaque brachytherapy and fetal radiation exposure, how gestational age shapes timing, and the reassuring — if limited — evidence on placental spread and maternal survival.

  6. 17 Jun

    Episode 81: The Women in Retina survey - 5 years on

    Euretina will shortly relaunch the Women in Retina survey, building on the first dataset. In this podcast, Prof. Anat Loewenstein, Dr Federica Fossataro and Prof. Nicole Eter explore what has changed since the original 2021 study, what's new and why participation from the whole community - women and men alike - is essential to measuring real progress. The Women In Retina Initiative is sponsored by Bayer.

  7. 2 May

    Episode 80: Geographic Atrophy: Rethinking Endpoints and Real-World Impact

    New therapies are reshaping geographic atrophy—but are trial endpoints keeping pace with clinical reality? Anat Loewenstein is joined by Sobha Sivaprasad and Kristina Pfau to examine how success in GA is measured, from lesion growth to functional vision. The panel explores microperimetry, contrast sensitivity, and emerging tools that may better reflect meaningful patient outcomes.

  8. 1 Apr

    Episode 79: Decoding Stargardt: New Treatments, Genetics, and What Lies Ahead

    A landmark Phase 3 trial has delivered the first positive result for Stargardt disease treatment — but the therapeutic landscape is shifting fast. Prof. Maximilian Pfau enjoys a discussion with Prof. Carel Hoyng and Dr. Karolina Kaminska on the ABCA4 disease spectrum, the groundbreaking discovery of AP5 complex-related macular dystrophy, and emerging therapies from oral drugs to gene-specific approaches

See All (87)

Ratings & Reviews

5
out of 5
2 Ratings

About

Expert Discussions from the World of Retina: Exploring the latest developments in the field with world-renowned leaders. It will feature a monthly subspecialty journal club, panel discussions and interviews with key opinion leaders.

Information

  • Creator
    Whipsmart Media
  • Years Active
    2021 - 2026
  • Episodes
    87
  • Rating
    Clean
  • Copyright
    © Copyright 2022 All rights reserved.
  • Show Website
    Talking Euretina

You Might Also Like